Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.64 USD | -0.47% | -9.16% | -13.00% |
04-29 | J&J, Bristol Myers lose challenges to US drug price negotiation program | RE |
04-29 | Goldman Sachs Cuts Bristol-Myers Squibb's Price Target to $56 From $60 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.00% | 90.49B | |
+26.47% | 664B | |
+26.74% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.43% | 234B | |
+4.71% | 199B | |
-9.53% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol Myers Squibb : Berenberg Bank Adjusts Bristol-Myers Squibb PT to $71 From $75, Maintains Buy Rating